672 filings
Page 3 of 34
8-K
tv9bgyyxh3jhh8y6t7
3 Nov 22
Regulation FD Disclosure
7:32am
424B5
b8ksr de3q
12 Oct 22
Prospectus supplement for primary offering
4:58pm
S-8
bgecth5iejye
31 Aug 22
Registration of securities for employees
4:21pm
8-K
0vlqy cv3a0
17 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
980h5d
11 Aug 22
Abeona Therapeutics Reports Second Quarter 2022 Financial Results
7:30am
DEFA14A
hh3cmv
4 Aug 22
Additional proxy soliciting materials
5:00pm
8-K
cum8p8e
20 Jul 22
Other Events
7:30am
424B5
1n4mfodxtuukk
19 Jul 22
Prospectus supplement for primary offering
5:15pm
8-K
i5as0h vvcx9mgbf4j
30 Jun 22
Material Modifications to Rights of Security Holders
5:00pm
8-K
9oy6u
14 Jun 22
Submission of Matters to a Vote of Security Holders
5:05pm
8-K
bo8 6yni29r38w15y87n
19 May 22
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule
7:35am
8-K
j2efo
17 May 22
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics
8:01am
8-K
s1soy1ckeye
13 May 22
Abeona Therapeutics Reports First Quarter 2022 Financial Results
7:30am
8-K
9ysit2v4s 6t5aeg4a4
2 May 22
Abeona Therapeutics Announces Pricing of $25 Million Private Placement of Convertible Redeemable Preferred Stock
5:14pm
8-K
246ezoz 6xa1dzyo2
29 Apr 22
Amendments to Articles of Incorporation or Bylaws
12:00am